Mark J. Bucsek

1.3k total citations
14 papers, 943 citations indexed

About

Mark J. Bucsek is a scholar working on Psychiatry and Mental health, Oncology and Immunology. According to data from OpenAlex, Mark J. Bucsek has authored 14 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 8 papers in Oncology and 4 papers in Immunology. Recurrent topics in Mark J. Bucsek's work include Cancer, Stress, Anesthesia, and Immune Response (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Stress Responses and Cortisol (3 papers). Mark J. Bucsek is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Stress Responses and Cortisol (3 papers). Mark J. Bucsek collaborates with scholars based in United States, Croatia and Czechia. Mark J. Bucsek's co-authors include Elizabeth A. Repasky, Bonnie L. Hylander, Guanxi Qiao, Minhui Chen, Thejaswini Giridharan, Cameron R. MacDonald, Jason W.‐L. Eng, Kathleen M. Kokolus, Kristopher Attwood and Lauren Evans and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark J. Bucsek

14 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Bucsek United States 11 582 279 233 203 144 14 943
Guanxi Qiao United States 9 590 1.0× 250 0.9× 225 1.0× 173 0.9× 154 1.1× 13 863
Cameron R. MacDonald United States 11 464 0.8× 219 0.8× 169 0.7× 162 0.8× 193 1.3× 21 795
Marganit Benish Israel 14 743 1.3× 294 1.1× 259 1.1× 127 0.6× 150 1.0× 22 1.1k
Caroline P. Le Australia 8 495 0.9× 201 0.7× 191 0.8× 137 0.7× 41 0.3× 12 724
Corina Kim-Fuchs Switzerland 6 359 0.6× 159 0.6× 123 0.5× 95 0.5× 38 0.3× 7 595
Juliana Croitoru‐Lamoury Australia 9 75 0.1× 108 0.4× 68 0.3× 194 1.0× 162 1.1× 9 814
Eero Rissanen Finland 19 87 0.1× 140 0.5× 68 0.3× 260 1.3× 133 0.9× 40 1.1k
Hisaka Kawate Japan 17 122 0.2× 106 0.4× 344 1.5× 360 1.8× 36 0.3× 33 702
Sarah Schock Canada 14 59 0.1× 47 0.2× 133 0.6× 448 2.2× 94 0.7× 29 874

Countries citing papers authored by Mark J. Bucsek

Since Specialization
Citations

This map shows the geographic impact of Mark J. Bucsek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Bucsek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Bucsek more than expected).

Fields of papers citing papers by Mark J. Bucsek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Bucsek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Bucsek. The network helps show where Mark J. Bucsek may publish in the future.

Co-authorship network of co-authors of Mark J. Bucsek

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Bucsek. A scholar is included among the top collaborators of Mark J. Bucsek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Bucsek. Mark J. Bucsek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Qiao, Guanxi, Minhui Chen, Hemn Mohammadpour, et al.. (2021). Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment. Cancer Immunology Research. 9(6). 651–664. 95 indexed citations
2.
Gandhi, Shipra, Manu Pandey, Kristopher Attwood, et al.. (2020). Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity. Clinical Cancer Research. 27(1). 87–95. 87 indexed citations
3.
Qiao, Guanxi, Minhui Chen, Hemn Mohammadpour, et al.. (2020). Adrenergic stress regulates the exhausted phenotype of T cells in the tumor microenvironment. The Journal of Immunology. 204(1_Supplement). 165.36–165.36. 1 indexed citations
4.
Gandhi, Shipra, Manu Pandey, Chong Wang, et al.. (2020). Impact of Concomitant Medication Use and Immune-Related Adverse Events on Response to Immune Checkpoint Inhibitors. Immunotherapy. 12(2). 141–149. 25 indexed citations
5.
MacDonald, Cameron R., Mark J. Bucsek, Guanxi Qiao, et al.. (2019). Adrenergic Receptor Signaling Regulates the Response of Tumors to Ionizing Radiation. Radiation Research. 191(6). 585–585. 30 indexed citations
6.
Qiao, Guanxi, Minhui Chen, Mark J. Bucsek, Elizabeth A. Repasky, & Bonnie L. Hylander. (2018). Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. Frontiers in Immunology. 9. 164–164. 116 indexed citations
7.
Qiao, Guanxi, Mark J. Bucsek, Minhui Chen, et al.. (2018). β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunology Immunotherapy. 68(1). 11–22. 125 indexed citations
8.
Bucsek, Mark J., Thejaswini Giridharan, Cameron R. MacDonald, Bonnie L. Hylander, & Elizabeth A. Repasky. (2018). An overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity. International Journal of Hyperthermia. 34(2). 135–143. 48 indexed citations
9.
Bucsek, Mark J., Guanxi Qiao, Cameron R. MacDonald, et al.. (2017). β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy. Cancer Research. 77(20). 5639–5651. 206 indexed citations
10.
Ito, Fumito, Amy Ku, Mark J. Bucsek, et al.. (2015). Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer. PLoS ONE. 10(11). e0143370–e0143370. 34 indexed citations
11.
Eng, Jason W.‐L., Chelsey B. Reed, Kathleen M. Kokolus, et al.. (2015). Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation. Nature Communications. 6(1). 6426–6426. 129 indexed citations
12.
Eng, Jason W.‐L., Chelsey B. Reed, Kathleen M. Kokolus, et al.. (2015). Abstract B72: Environmental temperature-induced chronic stress drives therapeutic resistance in murine tumor models through β2-adrenergic receptor activation. Cancer Immunology Research. 3(10_Supplement). B72–B72. 9 indexed citations
13.
Bucsek, Mark J., et al.. (2014). Enhancing the antitumor effects of adoptive cell transfer immunotherapy using preconditioning thermal ablation (TUM7P.956). The Journal of Immunology. 192(Supplement_1). 203.38–203.38. 1 indexed citations
14.
Vella, Joseph B., Seth D. Thompson, Mark J. Bucsek, Minjung Song, & Johnny Huard. (2011). Murine and Human Myogenic Cells Identified by Elevated Aldehyde Dehydrogenase Activity: Implications for Muscle Regeneration and Repair. PLoS ONE. 6(12). e29226–e29226. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026